Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel M Forton

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Time-series analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 14, 2020
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

Emma H Baker, Kamal Patel, Jonathan Ball

|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed.

Kathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick

Pageof 1

Frequent Collaborators

1 joint publications

Kathryn Drysdale

1 joint publications

Yevedzo Ntuli

1 joint publications

Kosh Agarwal

1 joint publications

Ahmed M Elsharkawy

1 joint publications

Graham R Foster

1 joint publications

Emma H Baker

Frequent Collaborators

1 joint publications

Kathryn Drysdale

1 joint publications

Yevedzo Ntuli

1 joint publications

Kosh Agarwal

1 joint publications

Ahmed M Elsharkawy

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

946
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on : Sep 25, 2019

7.3K
See more related videos

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

946
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on : Sep 25, 2019

7.3K
See more related videos